Virajkumar B Gandhi

USPTO Granted Patents = 15 (Patent Applications = 3)

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 10 (Patent Applications = 7)

Average Co-Inventor Count = 5.7

ph-index = 6

Forward Citations = 232(Granted Patents)

Location History:

Park City, IL (US) (2004 - 2012)
Gurnee, IL (US) (2011 - 2016)

Company Filing History:

9 out of 4,179

Abbott Laboratories Corporation

1 out of 832,880

Other

patents

Years Active: 2004-2016

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9283222 - Inhibitors of poly(ADP-ribose)polymerase (2016-03-15),

2. 9051327 - Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases (2015-06-09),

3. 8697736 - 1H-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors (2014-04-15),

4. 8546368 - Pyrazoloquinolones are potent PARP inhibitors (2013-10-01),

5. 8466150 - Inhibitors of poly(ADP-ribose)polymerase (2013-06-18),

6. 8450320 - Pyrrolopyrazinone inhibitors of kinases (2013-05-28),

7. 8383624 - Pyrrolopyrazine inhibitors of kinases (2013-02-26),

8. 8383623 - Phthalazin-(2H)-one inhibitors of kinases (2013-02-26),

9. 8217070 - 2-substituted-1H-benzimidazole-4-carboxamides are PARP inhibitors (2012-07-10),

10. 8143284 - Poly(ADP-ribose)polymerase inhibitors (2012-03-27),

11. 8067613 - Benzimidazole poly(ADP ribose)polymerase inhibitors (2011-11-29),

12. 7999117 - Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors (2011-08-16),

13. 7728026 - 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors (2010-06-01),

14. 7550603 - 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors (2009-06-23),

15. 6831175 - Kinase inhibitors (2004-12-14),

Title: Virajkumar B Gandhi: Innovator in Pharmaceutical Research

Introduction

Virajkumar B Gandhi is a prominent inventor based in Gurnee, IL (US). He has made significant contributions to the field of pharmaceutical research, holding a total of 15 patents. His work primarily focuses on developing innovative compounds that have the potential to treat various diseases, including cancer.

Latest Patents

Among his latest patents, Gandhi has developed inhibitors of poly(ADP-ribose) polymerase. These inhibitors, along with methods of making them and treating patients, are crucial in advancing cancer therapies. Another notable invention is the pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases. This invention relates to specific compounds and their pharmaceutical acceptable salts, which are useful for inhibiting kinases such as wee-1, thereby providing methods for treating diseases like cancer.

Career Highlights

Gandhi has worked with leading companies in the pharmaceutical industry, including Abbott Laboratories Corporation and AbbVie Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in drug discovery.

Collaborations

Throughout his career, Gandhi has collaborated with notable professionals in the field, including Gui-Dong Zhu and Thomas Dale Penning. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Virajkumar B Gandhi's contributions to pharmaceutical research and his innovative patents highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in cancer treatment and other therapeutic areas.

This text is generated by artificial intelligence and may not be accurate.